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Tercero, J.A., Longhese, M.P., and Diffley, J.F.X. (2003). Mol. CellA key issue that remains to be addressed concerns
11, 1323–1326.the regulation of the mechanism involved in sensing
Tyler, J.K., Adams, C.R., Chen, S.R., Kobayashi, R., Kamakaka, R.T.,the histone levels (step 3). How the different histone-
and Kadonaga, J.T. (1999). Nature 402, 555–560.interacting partners contribute to this sensing has not
Zhao, X., Chabes, A., Domkin, V., Thelander, L., and Rothstein, R.yet been established. It is intriguing that only exoge-
(2001). EMBO J. 20, 3544–3553.
nously provided CAC-1, but not Hir1/2, allows survival
Zhou, B.B., and Elledge, S.J. (2000). Nature 408, 433–439.of a rad53 mutant in the presence of excessive histones.
The nature of the interaction (affinity, stability) between
histones and their chaperones may be important in
“buffering” the pool of histones. It will be important to
examine how histones may be redistributed among their
different partners (chaperones), including Rad53, to Brain or Brawn:
allow the degradation only of histones in excess. How FGF Signaling Gives Us Both
These interactions could provide a possible means of
interfering with the stability of a Rad53-histone complex.
How the histones are actually degraded (step 4) and
how Rad53 provides the connection to a specific degra- How does FGF (fibroblast growth factor) signaling in-
dation pathway will also need to be determined. Histone duce both neural and mesodermal cell fates in the
degradation may be prevented by interaction with spe- early embryo? Two papers address this fundamental
cific chaperones. This could be particularly critical, in the question in this issue of Cell. Bertrand et al. show in
context of early development in Xenopus or Drosophila the ascidian that a GATA factor determines the neural
embryos, when maternal pools of histones are accumu- response of animal cells to FGF signaling, while in the
lated to fulfill the demands of rapid cell divisions during chick, Sheng et al. demonstrate that the slow induction
embryonic cell cycles. by FGF of a new transcription factor (Churchill) in the
This work has made use of S. cerevisae as a powerful neural plate in turn induces expression of Sip1 (Smad
model system to reveal an exciting new role for Rad53 in interacting protein-1), which inhibits mesodermal
a mechanism that ensures the maintenance of a steady genes and sensitizes cells to later neural inducing
state pool of histones. This function contributes to nor- factors.
mal cell growth and survival in the face of both DNA
damage and replication stress independently of the con- Following Spemann and Mangold’s initial observation
ventional checkpoint pathways. of neural induction by organizer-derived signals in the
Rad53 function is conserved among eukaryotes, and 1920s, developmental biologists have been in search of
the human homolog Chk2 acts as a tumor suppressor. the molecular basis of this process. A major break-
It will therefore be of major interest to determine if such through came some 10 years ago with the discovery
a mechanism is conserved and how it may contribute that inhibiting BMP (bone morphogenetic protein) sig-
to the basis of genomic instability found in cancer. naling in amphibian ectoderm promotes neural over epi-
Finally, this work emphasizes the fact that in addition dermal cell fates and that many BMP antagonists are
to sensing defects at the DNA level, checkpoint proteins expressed by the organizer. This led to the proposal
can allow cells to monitor parameters associated with of the “default model” for neural induction, in which
chromatin organization, in this case histone levels, in ectoderm cells form neural tissue unless they experi-
order to maintain genomic integrity. ence BMP signaling (Hemmati Brivanlou and Melton,
1997). This model has now been tested in higher verte-
brates. In particular, the formation of neural tissue inJean-Pierre Quivy and Genevie`ve Almouzni
mice lacking both BMP antagonists Noggin and Chordin
Institut Curie
(Wilson and Edlund, 2001) and misexpression experi-
Research Section
ments in the chick strongly suggest that inhibition of
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BMP signaling is not sufficient for neural induction in
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these contexts (Wilson and Edlund, 2001). More re-
France
cently, FGF signaling has emerged as a key conserved
pathway mediating neural induction. It is required to
Selected Reading
initiate this process in the chick (reviewed in Wilson
and Edlund, 2001), in ascidians (Hudson et al., 2003), inEmili, A., Schieltz, D.M., Yates, J.R., and Hartwell, L.H. (2001). Mol.
Cell 7, 13–20. Planaria (Cebria et al., 2002), and in mouse ES cells (Ying
et al., 2003), as well as, controversially, prior to the actionGunjan, A., and Verreault, A. (2003). Cell 115, this issue, 537–602.
of BMP antagonists in the amphibian embryo (WilsonHu, F., Alcasabas, A.A., and Elledge, S.J. (2001). Genes Dev. 15,
and Edlund, 2001). But FGF can also induce mesodermal1061–1066.
tissue in the early embryo, and an outstanding problemKaufman, P.D., Kobayashi, R., and Stillman, B. (1997). Genes Dev.
11, 345–357. is to understand how one signaling pathway can elicit
two such different outcomes. In this issue of Cell, Ber-Krawitz, D.C., Kama, T., and Kaufman, P.D. (2002). Mol. Cell. Biol.
22, 614–625. trand et al. (2003) and Sheng et al. (2003) describe the
transcriptional logic downstream of FGF signaling thatOsley, M.A. (1991). Annu. Rev. Biochem. 60, 827–861.
helps separate these distinct developmental programs.Sharp, J.A., Fouts, E.T., Krawitz, D.C., and Kaufman, P.D. (2001).
Curr. Biol. 11, 463–473. In the ascidian Ciona intestinalis, animal cells form
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neural tissue in response to FGF/MAPK signaling, and Sheng et al. (Claudio Stern’s lab) describes the action
of a further neural-specific transcription factor, ChurchillFGF can also induce mesoderm in vegetal cells. Here,
Bertrand et al. (work from Patrick Lemaire’s lab) analyze (ChCh), which, like GATA, contains two zinc fingers, and
which can be induced by either FGF4 or 8. Churchillthe regulation of Otx, the earliest gene known to be
expressed in prospective neural tissue, as a way to represses mesodermal genes and sensitizes cells to
further neural inducing signals.dissect the molecular mechanisms promoting the neural
cell fate in this simple chordate. They identify a DNA The exciting and key advance made by Sheng et al.
is to show that ChCh induces and is required for expres-sequence upstream of Otx that strongly enhances activ-
ity of this gene in a6.5 cells (ascidian neural precursors). sion of Sip1 (Smad-interacting protein 1) in the neural
plate, a known direct repressor of brachyury expression.This enhancer region (the a-element) is activated by
exogenous FGF treatment and depends on expression Detailed analysis of the Sip1 promoter region also identi-
fied multiple ChCh binding sites, suggesting that ChChof the endogenous gene FGF9/16/20. Further, analysis
of the a-element sequence revealed potential binding is a direct regulator of Sip1. The authors demonstrate
that ChCh represses brachyury in both frogs and chicks.sites for GATA and Ets transcription factors. Mutation of
the GATA and/or Ets sites suppressed a-element activity Importantly, ChCh is induced slowly in response to FGF,
and its onset in the neural plate coincides with the time atand reduced responsiveness to FGF signaling, sug-
gesting that during normal development, cooperation which epiblast cells stop ingressing through the anterior
primitive streak to form mesoderm. The authors strik-between these Ets and the GATA binding sites mediates
FGF action in prospective neural tissue. A key finding ingly show that ChCh expression arrests movement of
cells through the streak, while loss of ChCh leads tohere is that overexpression of a DNA fragment ( re-
porter) containing only Ets sites generates the same continued gastrulation. So, ChCh functions, via Sip1, to
keep cells in the neural plate and prevent expression oflevel of expression in both animal and vegetal cells, and
that FGF treatment activates this fragment in all cells. mesodermal genes. Since ChCh is induced slowly by
FGF and inhibits some of its early targets (i.e.,In contrast, GATA site fragments have activity, albeit
weak, in only animal cells, and this is dramatically in- brachyury), the authors point out that this provides a
mechanism to separate in time and space two functionscreased in just these cells when embryos are exposed
to FGF. So, while Ets sites mediate a general response of FGF, mesoderm induction and establishment of the
neural plate.to FGF, GATA sites appear to be animal-specific FGF
response elements. FGF signaling rapidly induces expression of preneural
genes, such as Sox3, but further signals are required toThe authors then identify Ets1/2 and GATAa as candi-
date endogenous regulators of a-element activity, and stabilize neural cell fate. Another well-known action of
Sip1 is its interaction with phospho-Smad1 (phosphory-using morpholinos demonstrate that both these factors
are indeed required for its activity. Crucially, they show lated downstream of BMP signaling), and in this way,
Sip1 regulates BMP signaling. It is not yet clear howthat only the Ets1/2 morpholino affects the expression
of the mesodermal gene brachyury in vegetal cells. Both this would work in the context of the neural plate, but
the authors argue that Sip1 expression here marks theEts1/2 and GATAa morpholinos reduce endogenous lev-
els of Otx in animal cells, while coinjection of both mor- onset of sensitivity to BMP signaling in the early neuro-
epithelium. Churchill was isolated in a screen for genespholinos leads to complete loss of a-element activity
and Otx expression. Further, introduction of a repressor differentially expressed 5 hr after initiation of neural
induction by FGF/organizer, and it is at this time thatform of GATAa specifically blocks Otx expression while
leaving brachyury unaffected, underscoring the conclu- cells become sensitive to BMP signaling/antagonists,
such as Chordin, which then stabilize neural cell fate assion that GATAa activity accounts for the distinct re-
sponse of animal cells to FGF signaling and targets the indicated by expression of Sox2 (Streit et al., 1998); this
clearly fits well with the onset of Sip1 in the neural plate.neural program to ectoderm.
Intriguingly, GATAa maternal mRNA is distributed Furthermore, recent analysis of mice lacking Sip1 re-
veals normal expression of Sox3, but very low levels ofubiquitously until the 64-cell stage, and the authors
show that protein synthesis is not needed for FGF to Sox2 (Van de Putte et al., 2003), and Sip1 binding sites
are also present in the Sox2 neural enhancers (Uchikawaactivate the a-element or Otx. This suggests that distri-
bution of GATAa protein may be all-important in this et al., 2003). These findings therefore strongly suggest
that Sip1 is a key mediator of the neural stabilizationprocess, and indeed the authors find that GATAa is
transiently localized in animal cell nuclei around the time step. The authors propose that Sip1 acts at the border
of the neural plate where BMPs are expressed, but it isof neural induction, as it coincides with the period during
which these cells are sensitive to Erk/MAPK signaling. worth noting that BMPs are also expressed at low levels
in the caudal neural plate (the epiblast adjacent to theFuture studies must now aim to establish how GATAa
nuclear localization is regulated. GATA factors are anterior primitive streak). Indeed, the authors have pre-
viously suggested that this region shares some charac-known effectors of BMP signaling, and although they
have been reported to be upregulated by FGF signaling teristics of the neural plate border, and fate mapping
studies reveal a mixture of future neural and epidermaland phosphorylated by Erk/MAPK in various contexts,
these latest experiments place them in a new light as cells in this region (Brown and Storey, 2000). Impor-
tantly, cells in the caudal neural plate progressively givemediators of specificity downstream of FGF signaling.
As the authors observe, in higher vertebrates, the in- rise to the spinal cord as the primitive streak regresses.
Sip1 may therefore be required not just at the edgescreased numbers of FGFs may allow dedication of spe-
cific FGFs to neural or mesodermal induction (e.g., Hard- of the neural plate, but as part of an ongoing neural
stabilization step (affecting epidermal and mesodermalcastle et al., 2000). However, work in the chick from
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cell fates) during the generation of the spinal cord. A
key future experiment now is to discover how ChCh
and Sip1 are regulated; as the authors point out, their
induction after 4 hr exposure to FGF suggests that other
signaling pathways are involved.
These two papers show that the ability of FGF to
induce both mesodermal and neural cell fates involves
the activity of neural-specific transcription factors,
which, in the case of ChCh, have an inhibitory effect on
mesoderm specific genes. Churchill does not appear to
be in the Ciona genome (which is nearly complete), and
interestingly, the separation of mesoderm and neural
lineages in ascidians does not involve cell movements,
raising the possibility that ChCh is characteristic of ani-
mals in which mesoderm induction is linked to gastrula-
tion movements.
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